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Abstract 
Activation of spinal cord microglia contributes to the development of peripheral nerve injury‑induced neuropathic 
pain. However, the molecular mechanisms underlying microglial function in neuropathic pain are not fully under‑
stood. We identified that the voltage‑gated proton channel Hv1, which is functionally expressed in spinal microglia, 
was significantly increased after spinal nerve transection (SNT). Hv1 mediated voltage‑gated proton currents in spinal 
microglia and mice lacking Hv1 (Hv1 KO) display attenuated pain hypersensitivities after SNT compared with wildtype 
(WT) mice. In addition, microglial production of reactive oxygen species (ROS) and subsequent astrocyte activation in 
the spinal cord was reduced in Hv1 KO mice after SNT. Cytokine screening and immunostaining further revealed that 
IFN‑γ expression was compromised in spinal astrocytes in Hv1 KO mice. These results demonstrate that Hv1 proton 
channel contributes to microglial ROS production, astrocyte activation, IFN‑γ upregulation, and subsequent pain 
hypersensitivities after SNT. This study suggests Hv1‑dependent microglia‑astrocyte communication in pain hypersen‑
sitivities and identifies Hv1 as a novel therapeutic target for alleviating neuropathic pain.
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Introduction
Peripheral nerve injury often results in neuropathic pain, 
which persists even after the initial injury heals. Such 
hypersensitivities are typically manifest as increased sen-
sitivity to normally painful (hyperalgesia) and normally 
painless (allodynia) stimuli. It is well accepted that neu-
ropathic pain is due to pathological alterations of both 
peripheral and central nociceptive neural networks [1]. 
However, recent studies have shown that glial-neuronal 
interactions play a key role in central sensitization and 
neuropathic pain outcomes [2, 3]. In particular, there is 
sequential activation of neurons, microglia, and astro-
cytes in the spinal cord after peripheral nerve injury [4, 
5].
Microglia, the resident immune cells in the central 
nervous system (CNS), are extremely sensitive to the 
brain microenvironment [6–9]. Peripheral nerve inju-
ries reliably induce microglial activation, which is indi-
cated by hypertrophic morphologies, proliferation, 
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gene expression alterations, and release of cytokines/
chemokines [3, 10]. Using microglia ablation and chemo-
genetic approaches, studies have shown that microglial 
proliferation and neuroinflammation in response to nerve 
injury are key players in the induction of pain hypersen-
sitivities [11–15]. Interestingly, optogenetic activation 
of spinal microglia is able to directly trigger “microglio-
genic pain” [16]. The most well-known molecular mecha-
nism involves microglial P2X4 receptor (P2X4R), which 
induces BNDF release and dis-inhibition in spinal lamina 
I neurons leading to pain hyperalgesia [17–20]. Many 
microglial receptors and ion channels, including P2Y12R, 
P2X7R, CCR2,  CX3CR1, and NADPH oxidase 2 (Nox2) 
are also reported to promote neuropathic pain [5, 21–23]. 
In addition to microglia, peripheral nerve injuries also 
induce spinal astrocyte activation with increased glial 
fibrillary acidic protein (GFAP) expression. The release of 
pro-inflammatory cytokines/chemokines from activated 
spinal astrocytes, such as IFN-γ, MCP-1, and CXCL1, is 
able to prolong hypersensitive pain state after peripheral 
nerve injuries [24].
Among inflammatory mediators released by micro-
glia and astrocytes, reactive oxygen species (ROS) play 
critical roles in both the  initiation and maintenance of 
chronic pain. ROS production is increased in the spinal 
cord after neuropathic pain and ROS scavengers or anti-
oxidants attenuated neuropathic pain [22, 25–27]. Recent 
studies have revealed that ROS generated by NADPH 
oxidases (NOX), including Nox2 and Nox4, contribute to 
neuropathic pain [22, 25, 26]. Nox2-deficient mice show 
attenuated mechanical allodynia and thermal hyperalge-
sia as well as reduced ROS generation, microglial acti-
vation, and pro-inflammatory cytokine expression after 
peripheral nerve injury [22].
Hv1 is a voltage-gated proton channel that was 
cloned in 2006 [28, 29] and later found to be specifically 
expressed in microglia, but not astrocytes or neurons 
[30–32]. Evidence indicates that Hv1 is coupled to NOX-
dependent acidosis, membrane depolarization, or ROS 
production in a variety of cells, including neutrophils 
[33], B cells [34], and eosinophils [35]. Previous studies 
demonstrated that microglial Hv1 proton channels con-
tribute to neuronal cell death through NOX-depend-
ent ROS production and brain damage after ischemic 
stroke, brain injury and demyelination [32, 36–40]. More 
recently, the Hv1 channel in spinal microglia was shown 
to contribute to spinal cord injury via ROS production, 
tissue acidification or autophagy mechanisms [41–43]. 
However, it is still unknown whether Hv1 is functional in 
spinal cord microglia that is important for neuropathic 
pain development. To this end, we examined the neu-
ropathic pain behaviors, glial activation, and cytokine 
profile after peripheral nerve injury using Hv1 knockout 
(KO) mice. We used male mice in the current study due 
to the critical sex differences in microglial involvement of 
neuropathic pain [44].
Results
The Hv1 proton channel is functionally expressed in spinal 
microglia and is upregulated after peripheral nerve injury
Gene profiling in the spinal cord after peripheral nerve 
injury showed the regulation of numerous genes related 
to immune function [45, 46]. In addition, activated 
microglia undergo proliferation in the ipsilateral dor-
sal horn of the spinal cord after peripheral nerve injury 
and promote neuropathic pain [12, 47, 48]. Hv1 proton 
channel is a major ion channel in microglia. However, 
the function of Hv1 in spinal cord microglia in pain is 
largely unknown. Using  CX3CR1GFP/+ mice, we per-
formed whole-cell recording in GFP-labeled microglia 
from acute spinal cord slices harvested from naïve mice 
(Fig. 1A). At a holding potential of − 60 mV with intracel-
lular pH5.5, a series of depolarizing voltage steps induced 
outward proton currents in spinal microglia in WT mice. 
The voltage-gated proton currents were likely mediated 
by the Hv1 channel, as currents were totally abolished in 
Hv1 KO mice (Fig. 1A, B). Therefore, the Hv1 channel is 
functionally expressed in spinal microglia as like that in 
brain microglia [32].
To examine if Hv1 protein expression is regulated after 
peripheral nerve injury, we used spinal nerve transec-
tion (SNT) in mice, a well-established mouse model of 
neuropathic pain. Spinal dorsal horn tissues were col-
lected for Western blot analysis following SNT at vari-
ous postoperative days (POD). We found that the Hv1 
protein levels were significantly upregulated at POD1 to 
POD5 (Fig. 1C, D). The transient upregulation of spinal 
Hv1 after SNT is paralleled with the critical time window, 
during which microglia participate in  neuropathic pain 
development [3, 49].
The Hv1 proton channel contributes to neuropathic pain 
behaviors after SNT
The upregulation of Hv1 in microglia after SNT suggests 
that the channel may participate in neuropathic pain. 
To directly test this idea, we compared the pain behav-
iors between WT and Hv1 KO mice after SNT. First, 
acute pain behaviors were tested and we found that Hv1 
KO mice exhibited similar responses to a tail flick test as 
WT mice (Fig. 2A). Moreover, basal motor behaviors in 
Hv1 WT and KO mice were similar (Fig.  2B). Next, we 
examined chronic pain behaviors, including mechani-
cal allodynia and thermal hyperalgesia, after SNT. WT 
mice developed both mechanical allodynia and thermal 
hyperalgesia that reached a plateau by the third postop-
erative day (Fig.  2C, D). Hv1 KO mice also developed 
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SNT-induced pain hypersensitivity (Fig.  2C, D). How-
ever, Hv1 KO mice showed significant improvement in 
pain hypersensitivities on POD 5–7 but not POD 1–3 
compared with WT mice. The attenuation of neuropathic 
pain in the later phase following SNT in Hv1 KO mice 
suggests a possible role of Hv1 channel function in neu-
ropathic pain maintenance.
To confirm that the behavioral phenotype in Hv1 KO 
mice after SNT extends to other nerve injury models, 
we repeated the behavioral experiments after ligation 
of common peroneal nerve ligation (CPN). This neuro-
pathic pain model employs a less invasive procedure and 
produces little muscle damage. Thus the animals recover 
quickly from the surgery with less motor dysfunctions 
[50]. As with the SNT model, the behavioral phenotypes 
of Hv1 KO mice could be distinguished from WT mice in 
the CPN model (Fig. 2E, F). Taken together, these results 
indicate that microglial Hv1 channel plays a significant 
role in the maintenance of pain hypersensitivities, as 
demonstrated by two neuropathic pain models.
Microglial proliferation and MAKP p38 activation 
in the spinal cord persist in Hv1 KO mice after SNT
Robust proliferation of spinal microglia occurs after SNT 
and is an important feature of microgliosis during neuro-
pathic pain [12, 47]. Since the Hv1 channel is specifically 
expressed in microglia, we first examined microgliosis 
after SNT beginning with microglial proliferation. By 
Fig. 1 Hv1 is functionally expressed in spinal microglia and upregulated after SNT. A Representative images of an acute spinal cord slice with a 
patched GFP‑expressing microglia (boxed area was enlarged, upper). Scale bar: 200 µm (left), 40 µm (right). Outward proton currents induced 
by voltage steps in spinal cord microglia (lower). Increased  pHi decreased the outward proton current and shifted the activation threshold to 
more depolarized potentials in WT microglia. No outward current was observed in Hv1 KO microglia. B I/V curves showing that Hv1 KO abolished 
voltage‑gated proton currents in spinal cord microglia (n = 6 cells from 3 mice each group). C, D Representative Western blot images (C) and 
quantification data (D) showing that Hv1 expression in the L4‑5 level of the dorsal horn increased at POD1‑7 after SNT. Data are presented as 
mean ± SEM, n = 4–5 mice/group. **p < 0.01, ***p < 0.001, GAPDH was used as internal control. Spinal cord tissue from Hv1 KO animals was used as 
a negative control to confirm the antibody specificity, one‑way ANOVA with multi comparisons
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immunostaining of microglial marker Iba1 in mice, we 
quantified microglial cell numbers in the ipsilateral dor-
sal horn at POD7 after SNT. For proliferation, we labeled 
spinal cord tissues with 5-bromo-2′-deoxyuridine (BrdU) 
(Fig. 3A). Our results showed that microglial cells in the 
ipsilateral dorsal horn were about 5 folds that of the con-
tralateral dorsal horn for both WT and Hv1 KO mice. 
The density of BrdU-positive microglia was about 30% 
Fig. 2 Hv1 is required for pain hypersensitivity after SNT. A, B WT and Hv1 KO animals exhibit similar acute pain phenotypes in a tail flick test (A) 
and motor learning capabilities in a rotarod test (B). Data are presented as mean ± SEM, n = 5—6 for each group. WT vs. Hv1 KO., unpaired t‑test for 
tail flick, one‑way ANOVA for rotarod. C, D Hv1 KO mice display reduced mechanical allodynia (C) and thermal hyperalgesia (D) following SNT. Data 
are presented as mean ± SEM, n = 14 mice for each group. **p < 0.01. WT ipsi vs. Hv1 KO ipsi., unpaired t‑test. E, F Hv1 KO animals show reduced 
mechanical allodynia (E) and thermal hyperalgesia (F) following CPN ligation. Data are presented as mean ± SEM, n = 8 for WT, n = 7 for Hv1 KO. 
**p < 0.01; ***p < 0.001. WT ipsi vs. Hv1 KO ipsi., unpaired t‑test
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and also similar between WT and Hv1 KO mice (Fig. 3C). 
These data indicate that SNT-induced microglial cell pro-
liferation was not affected by Hv1 deficiency.
MAPK p38 is predominantly expressed in spinal 
microglia and p38 phosphorylation (p-p38) is critical for 
microglial activation, which triggers several downstream 
pathways such as P2X4R upregulation, BDNF/cytokine 
release, and proliferation following neuropathic pain [51, 
52]. Thus, we examined the p-p38 expression using dou-
ble immunostaining together with Iba1 at POD3 after 
SNT. We found that p-p38 positive signals expressed in 
 Iba1+ microglia (Fig.  3B). In the ipsilateral dorsal horn, 
Iba1-labelled microglia showed a hypertrophic morphol-
ogy with enlarged somata compared to those in the con-
tralateral dorsal horn (see inserts in Fig.  3B). Statistical 
analysis showed that the fluorescent intensity of p-p38 
signals was significantly increased in the ipsilateral dor-
sal horn compared to the contralateral side and there was 
no difference between WT and Hv1 KO mice (Fig. 3D). 
Together, our results indicate that Hv1 deficiency did 
not affect spinal microglial activation as determined by 
microglial cell numbers, proliferation, and p38 activation 
following SNT.
Hv1‑dependent ROS production in microglia contributes 
to the neuropathic pain
Hv1 channel is known to participate in NOX-dependent 
ROS production in leukocytes and microglia [32, 53]. 
The proton current through Hv1 provides charge com-
pensation and balances intracellular acidification during 
ROS production [54, 55]. Increased and oxidized nucleic 
acid by ROS can be detected using an 8-hydroxyguanine 
(8-OHG) antibody in the spinal cord dorsal horn [22]. 
We found indeed 8-OHG signals were increased in Iba1-
positive microglia from ipsilateral dorsal horn after SNT. 
However, the 8-OHG signal was largely abolished in Hv1 
KO mice (Fig.  4A). The overall 8-OHG intensity in the 
ipsilateral horn was 3 folds that of the contralateral horn 
in WT mice and 1.4 fold that of the Hv1 KO ipsilateral 
horn (Fig.  4D). The overall background intensity of the 
contralateral horn was not different between WT and 
Hv1 KO samples (data not shown). Next, we measured 
superoxide generation in L4 microglia with oxidized-
Dihydroethidium (ox-DHE) after SNT. DHE (10  µg in 
5 µl ACSF) was intrathecally injected 2 h before the mice 
were sacrificed. Positive ox-DHE signals appear as bright 
red puncta within microglia (Fig.  4B). Consistent with 
the results using 8-OHG, the specific ox-DHE signal on 
microglia from Hv1 KO samples was significantly weaker 
than that from the WT (Fig. 4E). Finally, we also inves-
tigated the functional expression of NADPH oxidase 
(NOX) in Hv1 KO mice following SNT by immunostain-
ing for  gp91phox (NOX2). We found Hv1 KO spinal cords 
exhibited significantly lower  gp91phox expression com-
pared to Hv1 WT tissues 3 days after SNT (Fig. 4C, F). 
Therefore, our results demonstrate that ROS production 
was impaired in Hv1 KO mice after peripheral nerve 
injury.
Considering the important role of ROS in the chronic 
pain pathogenesis, the abrogation of ROS production in 
Hv1 KO mice may contribute to the attenuation of pain 
hypersensitivities after SNT. To test this idea, ROS scav-
enger sulforaphane (SF, 50  mg/kg, i.p.), which exerts its 
antioxidant effect by inducing nuclear translocation 
of Nrf-2 with subsequent heme oxygenase-1 (HO-1) 
expression in myeloid cells [22], was treated at 1  h fol-
lowing SNT. We found that treatment of WT mice with 
SF attenuated mechanical allodynia (Fig.  4G). However, 
SF did not affect pain hypersensitivities of Hv1 KO mice 
after SNT (Fig. 4G). Together, these results indicate that 
Hv1 deficient animals generate less ROS, which contrib-
utes to the amelioration of neuropathic pain phenotypes 
after SNT.
Astrocyte activation was reduced in the spinal cord of Hv1 
KO mice after SNT
Astrocytes are important for neuropathic pain develop-
ment, especially in the late maintenance phase [24, 56]. 
The fact that the neuropathic pain attenuation in Hv1 KO 
mice appeared in the late phase led us to study astrocyte 
involvement. SNT induced a dramatic GFAP expres-
sion on the ipsilateral dorsal horn on POD7 compared 
to contralateral side, which appeared in both superficial 
and deeper lamina in WT mice (Fig. 5A, C). In Hv1 KO 
Fig. 3 Hv1 deficiency does not alter microglial activation after SNT. A Representative images of Iba1 (top panels), BrdU (middle panels) and merged 
(bottom panels) immunoreactivity in the ipsilateral dorsal horn in control (left), SNT‑induced WT (center) and SNT‑induced Hv1 KO (right) mice 
at POD7. Inserts are higher magnification of boxed regions in the representative low magnification images. B Representative images of Iba1 (top 
panels), phosphorylated p38 (p‑p38, middle panels) and merged (bottom panels) immunoreactivity in the ipsilateral dorsal horn in control (left), 
SNT‑induced WT (center) and SNT‑induced Hv1 KO (right) mice at POD3. Inserts are higher magnification of boxed regions. Scale bar:100 µm. C 
Quantitative summary of microglial density in the contralateral and ipsilateral dorsal horn as well as BrdU + microglia density in the ipsilateral 
dorsal horn at POD7 following SNT in WT and Hv1 KO mice (n = 10 slices from 3 mice for each group, unpaired t‑test). D Quantitative p‑p38 
immunoreactivity in the contralateral and ipsilateral dorsal horn of WT and Hv1 KO mice. Data are presented as mean ± SEM, cells were randomly 
picked from 6 slices for each group. WT vs. Hv1 KO., unpaired t‑test
(See figure on next page.)
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Fig. 3 (See legend on previous page.)
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Fig. 4 SNT‑induced ROS production is attenuated in Hv1 KO mice. A Representative images of 8‑OHG (top) and merged 8‑OHG/Iba1 (bottom) 
immunostaining in WT (left) and Hv1 KO (right) spinal cord at POD7 after SNT. B Representative images of ox‑DHE (top) and merged ox‑DHE/
CX3CR1‑GFP (bottom) signals in WT (left) and Hv1 KO (right) spinal cord at POD3 after SNT. C Representative images of  Gp91
phox (top) and merged 
 Gp91phox/Iba1 (bottom) immunostaining in WT (left) and Hv1KO (right) spinal cord at POD1 after SNT. Scale bar: 50 µm. D–F Quantitative data 
showing 8‑OHG, ox‑DHE and  Gp91phox signal in the ipsilateral dorsal horn after SNT. Data are presented as mean ± SEM, 7–15 slices from 3 mice 
for each group. *p < 0.05; **p < 0.01; ***p < 0.001. WT vs. Hv1 KO unpaired t‑test. G Mechanical allodynia in WT and Hv1 KO mice treated with and 
without ROS scavenger, sulforaphane (SF), 1 h after SNT (arrow). SF treatment significantly attenuated mechanical allodynia in WT mice when 
compared to control group (WT + saline) but not in H1KO mice with SF or saline treatment. Data are presented as mean ± SEM, n = 7 mice for each 
group. **p < 0.01; ***p < 0.001, unpaired t‑test
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mice, GFAP induction was significantly reduced (Fig. 5A, 
C). To test the role of Hv1-dependent ROS production in 
astrocyte activation, we examined the effect of SF treat-
ment. We found that GFAP expression in WT mice was 
greatly reduced in both superficial and deep lamina after 
SF treatment (Fig.  5A, C). Notably, SF treatment also 
reduced microglial activation shown as reduced cell den-
sities compared with saline group (Fig. 5D). These results 
strongly indicate that SNT induced spinal astrocyte acti-
vation requires Hv1 and ROS production in microglia.
Reduced astrocytic IFN‑γ mediates attenuated pain 
hypersensitivity in Hv1 KO mice after SNT
Since spinal cytokines are critical for neuropathic pain 
pathogenesis [3, 5, 57], we investigated potential differ-
ences between cytokine expression in WT and Hv1 KO 
mice. The mRNA expression levels were examined using 
real-time PCR from spinal cord L4 segments at POD3 
after SNT. Interestingly, we found that BDNF, TNF-α, 
IL-1β, and IL-18 were expressed at similar levels in WT 
and Hv1 KO tissues. However, IFN-γ expression levels 
were abolished in Hv1 KO tissues (Fig. 6A).
IFN-γ is reported to be able to activate microglia 
through IFN-γ receptors and induce chronic pain [23, 
45]. The absence of IFN-γ induction we observed in Hv1 
KO mice after SNT could contribute to neuropathic pain 
attenuation. To test this hypothesis, we first used fluores-
cent immunostaining to detect the SNT induced IFN-γ 
expression in spinal dorsal horn on both POD3 and 
POD7 (Fig.  6B). We found that the intensities of IFN-γ 
were positively correlated with hypertrophic astrocyte 
morphologies and high expression of GFAP (Fig.  6B, 
inserts). The basal expression of IFN-γ in the contralat-
eral dorsal horn of Hv1 KO mice was similar to that in 
Fig. 5 Reduced astrocyte activation in Hv1 KO spinal cord after SNT. A Representative images of Iba1 (top panels), GFAP (middle panels) and 
merged (bottom panels) immunoreactivity in dorsal horn of control (the contra side of a WT sample was shown, left), the ipsilateral of SNT‑induced 
WT (left center), SNT‑induced Hv1 KO (right center), and sulforaphane‑treated SNT‑induced WT (right) mice at POD 7. Inserts are higher 
magnification of boxed regions. Scale bar: 100 µm. B–D Sample dorsal horn slice (B) is labelled with GFAP‑astrocytes (green) and Iba1‑microglia 
(red) highlighting the different lamina of the spinal cord. Astrocytes (C) and microglia (D) density were quantified in WT and Hv1 KO tissues at POD 
7. Scale bar: 100 µm. Data are presented as mean ± SEM, images obtained from 3 mice for each group. **p < 0.01; ***p < 0.001, unpaired t‑test
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WT tissues. However, IFN-γ induction in the ipsilateral 
dorsal horn was largely abolished at POD3 and POD7 
after SNT (Fig. 6C).
Next, to directly test the function of IFN-γ in the spi-
nal cord, we intrathecally injected IFN-γ neutralizing 
antibodies (1 μg in 5 μl ACSF) into WT mice after neu-
ropathic pain was established following SNT. We found 
that neutralizing endogenous IFN-γ partially reversed the 
mechanical allodynia within 24  h of the infusion of the 
antibody. However, the mechanical allodynia returned 
to saline group level after 72 h (Fig. 6D). In the Hv1 KO 
mice, IFN-γ antibody treatment after SNT did not affect 
the behavioral responses at any time point. These results 
suggest that endogenous IFN-γ and Hv1 are both neces-
sary for neuropathic pain maintenance.
Microglial Hv1 and astrocytic IFN‑γ mediate 
microglia‑astrocyte interaction in pain hypersensitivities
The reduced astrocytic IFN-γ expression and abolished 
IFN-γ-dependent neuropathic pain in Hv1 KO mice indi-
cate microglial Hv1 and astrocytic IFN-γ mediates the 
microglia-astrocyte interaction underlying pain hyper-
sensitivities. To test this hypothesis, we intrathecally 
injected IFN-γ (100U in 5 μl ACSF) at POD3 after SNT 
and then examined the pain hypersensitivities in Hv1 KO 
mice. We found that IFN-γ could restore the mechani-
cal allodynia in Hv1 KO mice, decreasing the paw with-
drawal threshold to the WT mice levels at 24 h after SNT 
(Fig.  7A). The rescue effect was transient and the pain 
hypersensitivities gradually disappeared at POD 5 and 7 
(Fig. 7A).
Exogenous IFN-γ triggers microglial proliferation and 
increases pain hypersensitivities [23]. To clarify the Hv1 
role in IFN-γ-induced pain increase, we performed IFN-γ 
infusion experiments with both naïve WT and Hv1 KO 
mice by intrathecal injection of IFN-γ (100U in 5  μl 
ACSF). Mechanical allodynia was successfully induced in 
WT mice with a peak at 2 days after the injection. In Hv1 
KO mice, a similar lower threshold decrease appeared 
at 24  h after the injection but then recovered quickly 
on subsequent days (Fig. 7B). Iba1 staining showed that 
microglia cell densities were doubled compared with the 
naive mice in both the WT and Hv1 KO groups (Fig. 7C, 
D). Thus, exogenous IFN-γ can induce proliferation of 
Hv1 KO microglia similarto WT ones. To study if astro-
cytes were activated subsequently to IFN-γ infusion, 
GFAP immunostaining was performed on IFN-γ-infused 
animals. We found that IFN-γ treatment induced robust 
astrocyte activation (GFAP expression) in WT mice, 
while GFAP upregulation was much less pronounced in 
the Hv1 KO mice (Fig.  7C, E). Therefore, these results 
suggest that IFN-γ induced allodynia requires Hv1-
dependent astrocyte activation.
Discussion
The current study demonstrates that microglial Hv1 pro-
ton channels contributed to ROS generation, astrocyte 
activation, IFN-γ production, and the subsequent neu-
ropathic pain following peripheral nerve injury (Fig.  8). 
These results provide novel insights into Hv1 function in 
microglia-astrocyte interaction and the pathogenesis of 
neuropathic pain. The microglial Hv1-astrocytic IFN-γ 
axis of communication has not been previously appreci-
ated. Particularly, this study provides molecular mecha-
nisms underlying microglial Hv1 in microglia-astrocyte 
communication and a rationale for microglial Hv1 as a 
novel therapeutic target for the pain management.
Hv1 channel of spinal microglia in ROS production 
in neuropathic pain
ROS can be generated by NOX activation via transfer-
ring electrons from NADPH across the membrane and 
coupling these to molecular oxygen [58, 59]. The elec-
tron transfer rapidly depolarizes and acidifies these 
cells. Given that excessive depolarization and intracellu-
lar acidification inhibit further expulsion of electrons, a 
charge-compensating mechanism is needed to maintain 
NOX activity. Current evidence indicates that Hv1 is acti-
vated by NOX-dependent acidosis and membrane depo-
larization, as well as required for NOX-dependent ROS 
(See figure on next page.)
Fig. 6 Hv1 is required for astrocyte‑derived IFN‑γ to promote neuropathic pain after SNT. A Real‑time PCR analysis data showing mRNA expression 
fold change of glial‑derived cytokines in the spinal cord at POD3 after SNT. Data are presented as mean ± SEM, n = 6 runs from 3 sample pools, 
each sample pool contained 2 mouse samples for each group. *p < 0.05 unpaired t‑test. B Representative images of IFN‑γ (top panels) and IFN‑γ / 
GFAP merged (bottom panels) immunoreactivity in the ipsilateral dorsal horn in control (a naïve WT sample was shown, left), POD3 SNT‑induced 
WT (left center), and Hv1 KO (center), as well as POD7 SNT‑induced WT (right center) and Hv1 KO (right) tissues. Inserts are higher magnification 
of boxed regions. Scale bar: 50 µm. C Quantitation of IFN‑γ immunoreactivity in control as well as POD3 and 7 SNT‑treated WT and Hv1 KO 
mice. Data are presented as mean ± SEM, cells were randomly picked from 3 mice for each group. ***p < 0.001. WT vs. Hv1 KO, unpaired t‑test. D 
Mechanical allodynia in WT and Hv1 KO mice treated with or without neutralizing IFN‑γ antibody (anti‑IFN‑γ). Anti‑IFN‑γ (1 μg in 5 μl ACSF) was 
applied intrathecally at POD3 and POD4 after SNT. Anti‑IFN‑γ intrathecal injection attenuated mechanical allodynia in WT mice when compared to 
the control group (WT + saline) but not in HV1 KO mice with anti‑IFN‑γ or saline injection. Data are presented as mean ± SEM. n = 7 mice for each 
group, **p < 0.01, unpaired t‑test
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production in a variety of cells, including neutrophils 
[33], B cells [34], and eosinophils [35]. Our previous work 
indicated that functional Hv1 is exclusively expressed in 
microglia in the CNS, and was critical for NOX-depend-
ent ROS generation in microglia in situ and in vitro [32, 
36, 37, 42]. In the current study, we extend the function 
of microglial Hv1 into the spinal cord during neuropathic 
pain (Figs. 1, 2).
In the spinal cord, microglial NOX2 contributes to 
most of the SNT-induced ROS production as both 
microglial activation and neuropathic pain initiation 
were  reduced in NOX2 KO mice [22]. However, in our 
study, microglial activation was not altered and neuro-
pathic pain attenuation appeared in the maintenance 
phase in the Hv1 KO mice (Fig.  2), suggesting that the 
efficiency of ROS elimination is different between NOX2 
and Hv1 KO mice. Although we found a dramatic reduc-
tion in ROS-induced nucleic acid oxidization as indicated 
by 8-OHG staining in Hv1 KO mice, ROS production 
was still detectable within microglia as indicated by DHE 
staining (Fig. 4). These results suggest that the NOX acti-
vation was successfully initiated, but the ROS production 
could not persist after intracellular acidification as well 
as NOX2 upregulation was inhibited in Hv1 KO mice. In 
addition, NOX2 is partially functional in Hv1 KO micro-
glia after SNT, which might be sufficient to trigger micro-
glial activation. Alternatively, mediators responsible for 
SNT-induced microglial activation could be released 
independently of Hv1 function. Considering the impor-
tant function of dorsal root ganglion (DRG) macrophages 
in neuropathic pain [60], whether the  Hv1 channel in 
DRG macrophages contributes to pain phenotype in gen-
eral KO mice warrants the further investigation.
Hv1‑dependent microglia‑astrocyte communication 
in neuropathic pain
Progress in the RNA sequencing (RNA-seq) techniques 
demonstrated a multiple spectrum of reactive micro-
glial subtypes in the diseased conditions [61, 62]. Recent 
RNAseq studies showed that pro-inflammatory cytokine 
and immunomodulatory drivers: complements, FcɣRs, 
and INFs are the important upstream mediators of nerve 
injury-induced gene regulation in reactive microglia in 
abnormal maladaptive state over long periods of pain 
hypersensitivity [16]. It was well documented that micro-
glia are critical in developing neuropathic pain especially 
in the initiation, during which, the  release of BDNF, 
cytokines such as TNF-α and IL-1β are essential for the 
establishment of pain hypersensitivities [63, 64]. Here, 
we show that SNT-induced mRNA expression of these 
molecules was maintained at POD3 in Hv1 KO mice 
(Fig. 6A), which is consistent with the observation of the 
normal initiation of neuropathic pain. Microglial acti-
vation reaches peak levels at around 3  days after nerve 
injury as indicated by proliferation rates and p-38 activa-
tion [12, 51, 65]. Our previous study found that micro-
glia ablation before SNT could delay neuropathic pain, 
while microglia ablation at day 7 after SNT had very lim-
ited effects [64], consistent with several pharmacological 
studies with minocycline [66]. On the other hand, fluo-
rocitrate, an inhibitor of astrocyte function, could reverse 
mechanical allodynia during the maintenance phase of 
neuropathic pain [66–68]. The behavioral phenotype 
seen in Hv1 KO mice in which pain hypersensitivities 
were attenuated in the maintenance phase led us to con-
sider a possible role of microglia-astrocyte communica-
tion. Indeed, we observed reduced astrocyte activation as 
indicated by GFAP expression on POD7 in Hv1 KO mice 
(Fig. 5). Moreover, ROS scavenger sulforaphane dramati-
cally inhibited SNT induced GFAP expression in WT 
mice. These results indicate the function of Hv1-depend-
ent ROS in astrocytic activation and microglia-astrocyte 
interaction during SNT-induced neuropathic pain.
Recent studies have suggested intriguing interaction 
between microglia and astrocyte in a variety of neuro-
logical disorders [69–71]. Complement signaling and 
interleukins were shown to be the potential mediators for 
microglia-astrocyte interaction. This A1 type of astrocyte 
activation was also confirmed in a chronic post-surgical 
pain model in the spinal cord [72]. Here we demonstrate 
Hv1-dependent ROS production in microglia-astro-
cyte communication that drives neuropathic pain after 
peripheral nerve injury. In addition to ROS produc-
tion, recent studies raised an intriguing possibility that 
Fig. 7 Hv1 is required for IFN‑γ promotes neuropathic pain and astrocyte activation. A Mechanical allodynia in SNT mice treated with exogenous 
IFN‑γ. IFN‑γ (100U in 5 μl ACSF) was intrathecally applied at POD3 after SNT. Data are presented as mean ± SEM, n = 7 for control groups, n = 6 for 
IFN‑γ treated group. #p < 0.05, Hv1 KO + saline vs Hv1 KO + IFN‑γ, *p < 0.05, WT + saline vs. Hv1 KO + IFN‑γ, unpaired t‑test. B Mechanical allodynia 
in naïve mice treated with exogenous IFN‑γ. IFN‑γ (100U in 5 μl ACSF) was intrathecally applied after the baseline pain test. Data are presented as 
mean ± SEM, n = 6 mice for each group. **p < 0.01, ***p < 0.001. WT vs. Hv1 KO, unpaired t‑test. C Representative images of Iba1 (top panels), GFAP 
(middle panels) and merged (bottom panels) immunoreactivity in the dorsal horn in control (a naïve WT sample was shown, left), IFN‑γ–treated WT 
(center) IFN‑γ–treated Hv1 KO (right) mice at day 4 post injection. Scale bar: 50 µm. D, E, Quantification of microglia (D) and astrocyte (E) density at 
POD4 in Hv1 WT and KO mice following IFN‑γ treatment. Data are presented as mean ± SEM, n = 6 slices from 3 mice for each group. **p < 0.01. WT 
vs. Hv1 KO, unpaired t‑test
(See figure on next page.)
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Hv1-mediated proton extrusion could be important for 
microglial Hv1 function in brain injury and spinal cord 
injury [30, 38, 41]. Hv1-mediated proton release could 
lead to tissue acidosis, which activates proton-gated ion 
channels expressed in spinal neurons [73–75]. Future 
studies are needed to test whether protons released by 
Hv1 could regulate microglia-astrocyte communication 
important for the pathogenesis of neuropathic pain.
Astrocyte activation, IFN‑γ production and neuropathic 
pain
Accumulating evidence has shown the importance of 
astrocyte activation in neuropathic pain, which includes 
persistent activation of p-ERK, p-JNK and release 
of IL-1β, IFN-γ, MCP-1 and CXCL1 [24, 49]. One of 
the  astrocyte activation mechanisms involves IL-18 
released by microglia. IL-18 receptors are expressed in 
astrocyte and their activation are necessary for neuro-
pathic pain development [76]. Here, we show that in 
Hv1 KO mice, SNT-induced IL-18 mRNA expression 
was intact but GFAP expression and astrocyte related 
cytokine (IFN-γ) activation were reduced (Fig.  6A). In 
addition, the elimination of ROS either in Hv1 KO tissues 
or by application of a ROS scavenger was correlated with 
a reduction of GFAP expression (Figs. 4, 5). These results 
together strongly suggest a role of ROS in promoting spi-
nal astrocyte activation after nerve injury.
In cultured rat brain astrocytes, TGF-β1 activates 
ROS-dependent signaling pathway [77], including the 
extracellular signal-regulated kinase 1/2 (ERK1/2), 
c-Jun-N-terminal kinase (JNK) and NF-κB. In the spi-
nal cord, NOX2 is predominantly expressed in microglia 
[22]. Thus, microglial-derived ROS production could be 
involved in the astrocyte ERK and JNK activation to trig-
ger the downstream NF-κB and matrix metalloprotein-
ase (MMP) pathways. Indeed, several lines of evidence 
showed that MMP9 and MMP2 are involved in the neu-
ropathic pain development during the early initiation and 
late maintenance phases, respectively [78, 79]. Further 
study is needed to elucidate the molecular mechanisms 
by which ROS activates astrocytes in the spinal cord dur-
ing neuropathic pain.
IFN-γ is able to exert strong pro-inflammatory effects 
by neuronal and microglial activation [3, 57]. IFN-γ 
may reduce GluR1 expression on dorsal horn inhibi-
tory neurons and result in the disinhibition of synaptic 
activity and central sensitization [80]. Here, we showed 
that neutralizing spinal endogenous IFN-γ partially and 
transiently reversed pain allodynia (Fig.  6). Injection of 
IFN-γ at POD3 after SNT could restore the mechani-
cal allodynia in HV KO mice (Fig.  7A). In addition, 
mechanical allodynia was successfully induced by IFN-γ 
injection in naïve WT mice (Fig. 7B) indicating that per-
sistent IFN-γ expression is necessary for neuropathic 
Fig. 8 Schematic diagram showing Hv1‑dependent microglia‑astrocyte interaction in neuropathic pain. After peripheral nerve injury, spinal 
microglia are activated and accompanied with Hv1 proton channel dependent ROS production. ROS acts on both neurons and astrocytes, 
triggering IFN‑γ release. IFN‑γ in turn contributes to further microglia activation and microglia‑astrocyte interaction to maintain pain hypersensitivity 
after SNT
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pain maintenance. IFN-γ receptor deficient mice showed 
attenuated neuropathic pain [23]. Although IFN-γ is 
released by astrocytes, the IFN-γ receptor is mainly 
expressed by microglia [23]. In addition, IFN-γ recep-
tor deficiency reduced microglial activation after nerve 
injury, while intrathecal injection of IFN-γ induced 
microglial proliferation and pain hypersensitivity that 
lasts for several days [23]. In the current study, we found 
IFN-γ was still able to induce microglial activation in 
Hv1 KO mice, but could not trigger long-lasting pain 
hypersensitivity. However, the different timeline of Hv1 
upregulation (POD1-5) and IFN-γ upregulation (POD3-
7) suggests that microglial Hv1 activation and ROS gen-
eration could be the trigger for IFN-γ upregulation and 
astrocyte activation after peripheral nerve injury. More-
over, reactive astrocytes expressing pro-inflammatory 
cytokine such as IFN-γ could be neurotoxic reactive A1 
type in neuropathic pain [72]. Therefore, future study 
is needed to determine how astrocytic IFN-γ upregula-
tion promotes spinal neuron excitability and the central 
sensitization to induce neuropathic pain. Collectively, 
our current study indicates the importance of microglial 
Hv1-mediated ROS generation for microglia-astrocyte 




Mice were maintained in the animal facility at Rutgers 
University and Mayo Clinic. C57BL/6  J (Charles River), 
 CX3CR1GFP/+,  Hv1−/− (C57BL/6  J background), and 
 Hv1−/−/CX3CR1GFP/+ mice were used. Considering sex-
dependent role of microglia in neuropathic pain [44], 
we used all male mice for the current study. The geno-
type was blind to the experimenters. Lumbar 4 spinal 
nerve transection (SNT) surgery was done in 7–9 weeks 
old mice as described before [12, 81]. SNT surgery was 
performed under 2% isoflurane anesthesia. An incision 
was made along the middle line of lumbar spine. Left side 
paraspinal muscles in front of pelvis bone were separated 
to expose the L5 transverse process. The L5 transverse 
process was removed to expose L4 spinal nerve. The L4 
spinal nerve was separated and transected and removed 
1–1.5 mm from one end. The wound was then irrigated 
with PBS and closed with #6 silk sutures for the muscles 
and #5 silk sutures for the skin. All animal experiment 
protocols were reviewed and approved by the Institu-
tional Animal Care and Use Committee at Rutgers Uni-
versity and Mayo Clinic.
Behavioral measurement
Mechanical allodynia was assessed by measuring 
the paw withdrawal threshold with a set of Von Frey 
filaments (0.04–2  g; North Coast medical). Mice were 
placed on an elevated metal grid. The filament was 
applied to the plantar surface in vertical angle for 1–2 s 
from the bottom. 50% withdrawal threshold values 
were determined using the up-down method.
Thermal hyperalgesia was assessed by measuring the 
paw withdrawal latency to radiant heat stimuli. Mice 
were placed in elevated chambers with Plexiglas floor 
and allowed to habituate for 20  min. The radiant heat 
source (IITC Inc life science) was applied to the center 
of the plantar surface in the hind paw for 4 times with 
at least 5 min intervals. The average withdrawal latency 
of the 4 trials was recorded as the response latency.
For the tail flick test, mice were restrained in a cylin-
der with tail hung out. The mice were then placed on 
the test panel with the tail covered a detection hole at 
a fixed distance to the tail root. The same radiant heat 
was focused on the tail at the detection hole position. 
Tail flick will expose the hole to the light and trigger the 
sensor to record the latency time. The tests were done 
for 4 times with at least 5  min intervals. The average 
withdrawal latency of the 4 trials was recorded as the 
flick response latency.
The rotarod tests were performed using a four-lane 
Rotarod apparatus (Med Associates Inc). The rota-rod 
speed started from 4 Round Per Minute (RPM) and 
uniformly accelerated to 40 RPM in 5 min. Each mouse 
was tested for 3 times with 5 min intervals for the first 
day and one time for the next day.
Whole‑cell patch clamp recording in microglia
Whole-cell patch clamp recording was performed as 
reported previously [82, 83]. Mice were anesthetized 
with isoflurane and coronal slices (300  μm) of spinal 
cord were prepared. After 1 h of recovery, brain slices 
were perfused with oxygenated artificial cerebrospi-
nal fluid (ACSF) solution at 3–4  ml/min. NaCl was 
replaced with NaMeSO3 to eliminate potential Cl- cur-
rents. Whole-cell patch-clamp recordings in microglia 
were made using 5–10 MΩ glass pipettes filled with a 
TMA-based intracellular solution consisting of 100 mM 
TMA-MeSO3, 1 mM EGTA, and 100 mM MES (pH 5.5, 
290–300 mOsm). The membrane potential was held at 
− 60 mV. Data were amplified and filtered at 2 kHz by 
a patch-clamp amplifier (Multiclamp 700B), digitalized 
(DIGIDATA 1440A), stored, and analyzed by pCLAMP 
(Molecular Devices, Union City, CA). Data were dis-
carded when the input resistance changed > 20% dur-
ing recording. A minimum of five cells from at least 
three different mice from the same litter were randomly 
selected for recording per condition.
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Western blot analysis
Lumbar 4–5 spinal dorsal horns were collected and pro-
tein was extracted. 50 μg of protein from each group was 
then loaded and separated by SDS-PADGE, transferred 
to a PVDF membrane, blocked with 5% skim milk in 
TBST, and incubated overnight with primary antibod-
ies at 4  °C. Primary antibodies include, rabbit anti-Hv1 
(1:2000; AHC-001, RRID:AB_10917155, Alomone labs) 
and GAPDH (1:1000; sc-32233, RRID:AB_627679, Santa 
Cruz Biotechnology). Membranes were incubated with 
horseradish peroxidase-conjugated goat anti-rabbit 
IgG (1:2000; 111-036-045, RRID:AB_2337943, Jackson 
ImmunoResearch Labs) and horseradish peroxidase-
conjugated goat anti-mouse IgG (1:2000; 115-035-003, 
RRID:AB_10015289, Jackson ImmunoResearch Labs) for 
1 h at room temperature. Membranes were then treated 
with West Pico substrate (34078, Thermo Fisher Scien-
tific) and chemiluminescence signal was detected with a 
G:BOX Chemi XRQ gel doc (Syngene, Frederick, MD). 
Optical density of each band was then determined using 
Fiji, (NIH).
Real‑time qRT‑PCR
Total RNA from isolated L4 spinal cord tissue was 
extracted using TRIzol reagent (Invitrogen). Real-time 
qRT-PCR was performed using a 7500 Real-Time PCR 
system (Applied Biosystems) with oligonucleotide prim-
ers. The primer sequences are listed as Table  1. The 
threshold cycle (Ct) of the GAPDH gene was used as a 
reference control to normalize the expression level of the 
target gene (ΔCt) to correct for experimental variation. 
Relative mRNA levels were calculated according to the 
 2−ΔΔCt method. Real-time qRT-PCR experiments were 
performed at least three times, and the mean ± SEM val-
ues are presented unless otherwise noted.
Drug administration
For intrathecal (i.t.) drug administration, mice were 
hand restricted and injected by direct lumbar punc-
ture between L5 and L6 vertebrae of the spine, using a 
10-μL Hamilton syringe (Hamilton Bonaduz AG) with 
a 31G needle. Successful insertion was indicated by tail 
flick response. DHE (10 μg in 5 μl ACSF, prepared with 
100 mg/ml stock in DMSO), IFN-γ (100 ng in 5 μl ACSF), 
and IFN-γ neutralizing antibody (200  ng in 5  μl ACSF) 
were injected to awake mice at given time points after 
SNT. Sulforaphane (Calbiochem) was intraperitoneal 
(i.p.) treated. The stock solution was prepared in DMSO 
and diluted (1 mg/ml in 10% corn oil in PBS) just before 
use. BrdU (Sigma, 50 mg/kg in PBS) was i.p. injected at 
30 min before SNT surgery and then daily in the follow-
ing days with the same dose. The last injection was 4  h 
before the scarification.
In situ ROS detection
Dihydroethidium  (DHE), an oxidative fluorescent dye, 
was used to detect  ROS in the spinal cord after SNT 
surgery. To avoid reduction of ROS fluorescence during 
immunostaining, DHE (Sigma, 10 μg in 5 μl ACSF) was 
injected by direct lumbar puncture between L5 and L6 
vertebrae of the spine, using a 10-μL Hamilton syringe 
(Hamilton Bonaduz AG) with a 31G needle. Two hours 
after the DHE injection, the mice were anesthetized and 
perfused intracardially with 20 ml PBS followed by 20 ml 
of cold 4% paraformaldehyde (vol/vol) in PBS. The spinal 
cord was harvested similar to  that for immunostaining 
and stored in dark. The samples were then cryocut within 
48 h after perfusion fixation and imaged within 2 h after 
the slice mounting. DHE, DAPI signals, and the area of 
the microglial cell body were quantified with ImageJ 
software (US National Institutes of Health) by masking 
non-microglial cells. The oxidation of DHE in  vivo can 
generate multiple fluorescent products with overlap-
ping spectra, which may not be exclusively located in the 
nucleus.
Fluorescent immunostaining
The mice were deeply anesthetized with isoflurane (5% 
in  O2) and perfused transcardially with 40 ml PBS fol-
lowed with 40 ml cold 4% PFA in PBS. The spinal cord 
was removed and post-fixed with the same 4% PFA 
overnight at 4 °C. The spinal cord was then transferred 
to 30% sucrose in PBS for at least 24  h. Spinal cord 
transverse Sects.  (15  μm in thickness) were prepared 
Table 1 Primer sequences for qRT‑PCR
cytokine forward reverse
IFN‑γ AGC GGC TGA CTG AAC TCA GAT TGT AG GTC ACA GTT TTC AGC TGT ATA GGG 
IL‑18 ACT GTA CAA CCG CAG TAA TACGG AGT GAA CAT TAC AGA TTT ATCCC 
IL‑1β CCA AAA GAT GAA GGG CTG CT TCA TCA GGA CAG CCC AGG TC
TNF‑α ATG CTG GGA CAG TGA CCT GG CCT TGA TGG TGG TGC ATG AG
BDNF AGG CAC TGG AAC TCG CAA TG AAG GGC CCG AAC ATA CGA TT
GAPDH AAC TCC CTC AAG ATT GTC AGCAA GGC TAA GCA GTT GGT GGT GC
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on gelatin-coated glass slide with a cryocut microtome. 
The sections were blocked with 5% goat serum and 
0.3% Triton X-100 (Sigma) in TBS buffer for 1.5 h. The 
sections were incubated overnight at 4  °C with pri-
mary antibody for rabbit-anti-Iba1 (1:1000, Wako), 
mouse-anti-BrdU (1:200, Sigma), mouse-anti-8-OHG 
(1:200, Abcam), rabbit-anti-p-p38 (1:400, cell signal-
ing), mouse-anti-Nox2/gp91-phox (1:100, Santa Cruz), 
rat-anti-IFN-γ (1:100, eBioscience) rabbit-anti-BDNF 
(1:200, Alomone Labs Ltd,  Israel). The sections were 
then incubated for 1.5  h at RT with corresponding 
secondary antibodies (Alexa Fluor 555 & 488, Invitro-
gen). The sections were mounted with Fluoromount-
G (SouthernBiotech) and fluorescent images were 
obtained with a confocal microscope (LSM510, Zeiss). 
For BrdU staining, a pre-antigen retrieval process was 
made. Slices were immersed in 0.1 M citrate buffer (pH 
6.0) for 10  min, keeping the temperature at 92–98  °C. 
After a wash with PBS for 5 min at RT, slices were incu-
bated in 2  N HCl for 30  min and then washed in PBS 
for 10 min at RT. Regular staining process was under-
gone afterward.
Iba1 or BrdU positive cell densities and fluorescent 
signal intensity of 8-OHG and GFAP were quantified 
using ImageJ software (National Institutes of Health, 
Bethesda, MD). The intensity of ox-DHE, p-p38 were 
measured within GFP or Iba1 positive area, respec-
tively. The area mask and intensity measurement were 
done using a Matlab (The MathWorks, Inc.) script. 
IFN-γ and Nox2/gp91-phox were measured within 
GFAP positive area and done under ImageJ as well.
Statistics analysis
Quantification of fluorescent immunostaining 
results was done with Fiji version of ImageJ (Fiji, 
RRID:SCR_002285). Pain behaviors were analyzed 
using two-way ANOVA with multi comparisons to test 
for main effects between groups followed by post-hoc 
testing for significant differences. Two-group analy-
sis utilized the Student’s t-test. Three to four group 
analyses utilized a one-way ANOVA design. Data are 
expressed as mean ± SEM. All statistical analyses were 
performed using GraphPad Prism 8 software (Graph-
Pad Prism 8, RRID:SCR_002798). Level of significance 
is indicated with *p < 0.05, **p < 0.01, ***p < 0.001, 
****p < 0.0001.
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